Page last updated: 2024-12-08

articulin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

articulin: amino acid sequence given in first source; 80 & 86 kDa proteins in equimolar amts make up 60% of the peripheral membrane skeleton; members of a new class of membrane cytoskeletal proteins [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID156833
MeSH IDM0205997

Synonyms (9)

Synonym
articulins
articulin
5-hydroxy-7,8-dimethyl-7-[2-(5-oxo-2h-furan-3-yl)ethyl]-5,6,6a,8,9,10-hexahydro-1h-benzo[d][2]benzofuran-3-one
1h-naphtho(1,8a-c)furan-3(5h)-one, 7-(2-(2,5-dihydro-5-oxo-3-furanyl)ethyl)-6,6a,7,8,9,10-hexahydro-5-hydroxy-7,8-dimethyl-, (5s-(5alpha,6aalpha,7alpha,8beta,10ar*))-
75478-98-7
86 kd articulin
80 kd articulin
DTXSID60996930
5-hydroxy-7,8-dimethyl-7-[2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl]-6,6a,7,8,9,10-hexahydro-1h-naphtho[1,8a-c]furan-3(5h)-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.14 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.22 (0.95)

This Compound (27.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]